Omniscope
Dover, US · Founded 2021 · 37 employees on LinkedIn · 2 known investors
Find your way into Omniscope
1,017 people in our graph share verified history with the Omniscope team — schools, employers, funds. One of them is your warm intro.
Deep Nisharunlockedknows Vijay Vaswani · together at Stanford University (overlapped)
×5knows the team · via Stanford University
×2knows the team · via University of Sussex
knows the team · via IE Business School
knows the team · via Imperial College London
×2knows the team · via SDA Bocconi
Omniscope develops diagnostics and therapeutics technology based on the convergence of AI and immunology, aiming to interpret immune system data to generate therapeutics, develop diagnostics, and monitor patients. Founded in 2020, the company applies machine learning to immunology with a focus on health equity.
Founders & leadership
Omniscope was founded in 2021 by Holger, Lynnette, Matthew, and Vijay Vaswani.
H
HolgerinFounderHolger is a genomics scientist and ICREA Professor who leads the Single Cell Genomics Group at Spain's National Center for Genomic Analysis, where he develops single-cell and spatial sequencing technologies and participates in the Human Cell Atlas project. He is Chief Scientific Officer and co-founder of Omniscope, applying machine learning to immunology for diagnostic and therapeutic development.
L
LynnetteinFounder
M
MatthewinFounderMatthew leads technology initiatives at Omniscope, with background in Google Cloud Platform, machine learning, and software engineering.
VV

Vijay VaswaniinCo-Founder & CEOVijay Vaswani is founder of Omniscope, which applies machine learning to immunology to develop diagnostics and therapeutics while addressing health equity.
Investors · 2
Competitors · 3
by search overlapDescope7 shared keywordsDescope is a no/low-code customer identity and access management (CIAM) platform that lets developers build authentication and user journeys using a drag-and-drop visual editor, SDKs, or REST APIs. It supports passwordless login, MFA, SSO, SCIM provisioning, fine-grained authorization, and identity federation for consumer, business, and internal applications.
Crosscope4 shared keywordsCrosscope develops AI and machine learning technology for cancer screening and pathology diagnosis. The company provides computer-assisted diagnostic imaging analysis and automated image analysis tools for pathologists to improve workflow efficiency and diagnostic accuracy.
Tellescope4 shared keywordsTellescope provides a unified platform for digital health companies to manage patient communications, appointments, and care team operations. The platform includes patient portals, workflow automation, telehealth capabilities, and integrations with existing EHR systems.
Companies competing with Omniscope for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Omniscope do?
- Omniscope develops diagnostics and therapeutics technology based on the convergence of AI and immunology, aiming to interpret immune system data to generate therapeutics, develop diagnostics, and monitor patients. Founded in 2020, the company applies machine learning to immunology with a focus on health equity.
- Who founded Omniscope?
- Omniscope was founded by Holger, Lynnette, Matthew, Vijay Vaswani in 2021.
- Who are Omniscope's investors?
- Omniscope's investors include FoundersX Ventures, Buenavista Equity Partners.
- Where is Omniscope headquartered?
- Omniscope is headquartered in Dover, US.



